MANALI DEBNATH: Open Payments
NPI 1881175156 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 43 payments from 12 companies in 2025. Trend: 2023 $338 · 2024 $390 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $226 |
| Evofem Biosciences, Inc. | 14 | $147 |
| Neurocrine BioSciences, Inc. | 3 | $84 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Grifols USA, LLC | 1 | $37 |
| Exeltis, USA Inc. | 2 | $35 |
| Corium, LLC | 2 | $34 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Biogen, Inc. | 1 | $25 |
Products named: Veozah, Phexxi, INGREZZA, Jornay PM, Lynkuet, Gamunex-C, SLYND, Azstarys.
Industry payments across NY — which companies pay providers there.
